These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2623222)

  • 1. [A meeting of experts in Washington. Omeprazole: important progress in the treatment of gastric pathology. Activity and cicatrization rate in ulcer are highlighted].
    Rev Clin Esp; 1989; 185(3):suppl 2p.. PubMed ID: 2623222
    [No Abstract]   [Full Text] [Related]  

  • 2. Omeprazole: blocks gastric acid secretion completely.
    Drug Ther Bull; 1990 Jun; 28(13):49-52. PubMed ID: 2131211
    [No Abstract]   [Full Text] [Related]  

  • 3. [Omeprazole: a step forward in the therapy of acido-peptic disease].
    Piqué JM
    Med Clin (Barc); 1992 Jun; 99(5):179-82. PubMed ID: 1507897
    [No Abstract]   [Full Text] [Related]  

  • 4. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 7. [Omeprazole in peptic ulcer--pros and cons].
    Stasiewicz J
    Wiad Lek; 1986 Jun; 39(11):765-71. PubMed ID: 3535259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reply to the critique by Drs. Díaz de Rojas y Castelló Tapias].
    Cataldi R; Meeroff M
    Rev Esp Enferm Dig; 1991 Oct; 80(4):285-6. PubMed ID: 1805899
    [No Abstract]   [Full Text] [Related]  

  • 9. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
    Annibale B; D'Ambra G; Luzzi I; Marcheggiano A; Iannoni C; Paoletti M; Anania MC; Marignani M; Delle Fave G
    Am J Gastroenterol; 1997 May; 92(5):790-4. PubMed ID: 9149186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Helicobacter pylori colonization with omeprazole.
    Fukuda Y
    Scand J Gastroenterol Suppl; 1996; 214():54-5; discussion 57-60. PubMed ID: 8722408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term treatment with regular or high doses of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients.
    Udd M; Miettinen P; Palmu A; Julkunen R
    Scand J Gastroenterol; 2003 Jun; 38(6):588-93. PubMed ID: 12825865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Omeprazole. A new inhibitor of gastric secretion].
    Farup PG
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2156-7. PubMed ID: 2772881
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of omeprazole and placebo for bleeding peptic ulcer.
    Srinath C
    Trop Gastroenterol; 1997; 18(3):115-6. PubMed ID: 9385855
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical utility and safety of omeprazole.
    Walan A
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Omeprazole and peptic ulcer. Profile of a new active agent].
    Müller P; Dammann HG; Simon B
    Fortschr Med; 1987 Jan; 105(2):35-8. PubMed ID: 3557254
    [No Abstract]   [Full Text] [Related]  

  • 18. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly.
    Pilotto A; Di Mario F; Battaglia G; Vigneri S; Leandro G; Franceschi M; De Boni M; Grasso A; Vianello F; Naccarato R
    Clin Ther; 1994; 16(6):935-41. PubMed ID: 7697690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
    Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.